Hims & Hers Health, Inc. (HIMS) vs ELI LILLY & Co(LLY)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | HIMS | LLY |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $2.35B | $65.18B |
| Revenue growth (YoY) | ▲ 59.0% | ▲ 44.7% |
| Net income | $128.37M | $20.64B |
| Gross margin | 73.8% | — |
| Diluted EPS | $0.51 | $22.95 |
| Insider net (6 mo) | −1.8M sh · 23 sells · 1 buys | −31.0K sh · 5 sells · 0 buys |
| Institutional owners | 40 | 51 |
| Institutional value held | $6.17B | $533.23B |
| Next earnings (est.) | Around Nov 2, 2026 | Around Oct 29, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc., launched in 2017 and headquartered operations built around a consumer-first digital health platform, connects consumers with licensed healthcare providers for telehealth consultations and prescription and non-prescription products add
About ELI LILLY & Co (LLY)
Eli Lilly and Company, incorporated in Indiana in 1901 and tracing its roots to a drug manufacturing business founded in 1876, operates as a single-segment human pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative
Source: SEC EDGAR.